Literature DB >> 20142359

Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula.

Young-In Kim1, Jeoung-Eun Park, David D Brand, Elizabeth A Fitzpatrick, Ae-Kyung Yi.   

Abstract

Hypersensitivity pneumonitis is an interstitial lung disease that results from repeated pulmonary exposure to various organic Ags, including Saccharopolyspora rectivirgula, the causative agent of farmer's lung disease. Although the contributions of proinflammatory mediators to the disease pathogenesis are relatively well documented, the mechanism(s) involved in the initiation of proinflammatory responses against the causative microorganisms and the contribution of signaling molecules involved in the host immune defense have not been fully elucidated. In the current study, we found that S. rectivirgula induces the activation of protein kinase D (PKD)1 in lung cells in vitro and in vivo. Activation of PKD1 by S. rectivirgula was dependent on MyD88. Inhibition of PKD by pharmacological PKD inhibitor Gö6976 and silencing of PKD1 expression by small interfering RNA revealed that PKD1 is indispensable for S. rectivirgula-mediated activation of MAPKs and NF-kappaB and the expression of various proinflammatory cytokines and chemokines. In addition, compared with controls, mice pretreated with Gö6976 showed significantly suppressed alveolitis and neutrophil influx in bronchial alveolar lavage fluid and interstitial lung tissue, as well as substantially decreased myeloperoxidase activity in the lung after pulmonary exposure to S. rectivirgula. These results demonstrate that PKD1 is essential for S. rectivirgula-mediated proinflammatory immune responses and neutrophil influx in the lung. Our findings also imply the possibility that PKD1 is one of the critical factors that play a regulatory role in the development of hypersensitivity pneumonitis caused by microbial Ags and that inhibition of PKD1 activation could be an effective way to control microbial Ag-induced hypersensitivity pneumonitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142359      PMCID: PMC2987577          DOI: 10.4049/jimmunol.0903718

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis.

Authors:  E Israël-Assayag; A Dakhama; S Lavigne; M Laviolette; Y Cormier
Journal:  Am J Respir Crit Care Med       Date:  1999-06       Impact factor: 21.405

Review 2.  Extrinsic allergic alveolitis.

Authors:  Tengku Ismail; Charles McSharry; Gavin Boyd
Journal:  Respirology       Date:  2006-05       Impact factor: 6.424

Review 3.  Recognition of pathogenic microorganisms by Toll-like receptors.

Authors:  M G Netea; J W M Van der Meer; B J Kullberg
Journal:  Drugs Today (Barc)       Date:  2006-03       Impact factor: 2.245

Review 4.  Nod-like proteins in immunity, inflammation and disease.

Authors:  Jörg H Fritz; Richard L Ferrero; Dana J Philpott; Stephen E Girardin
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

5.  Respiratory epithelial cells release interleukin-8 in response to a thermophilic bacteria that causes hypersensitivity pneumonitis.

Authors:  G Gudmundsson; G W Hunninghake
Journal:  Exp Lung Res       Date:  1999 Apr-May       Impact factor: 2.459

6.  IFN-gamma production by innate immune cells is sufficient for development of hypersensitivity pneumonitis.

Authors:  Stephanie Nance; Richard Cross; Ae-Kyung Yi; Elizabeth A Fitzpatrick
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

7.  Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis.

Authors:  H Yamasaki; M Ando; W Brazer; D M Center; W W Cruikshank
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

8.  Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.

Authors:  Betty Lamothe; Arnaud Besse; Alejandro D Campos; William K Webster; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

Review 9.  [Clinical and immunopathological aspects of hypersensitivity pneumonitis].

Authors:  Y Lacasse; E Israël Assayag; M Laviolette; Y Cormier
Journal:  Rev Mal Respir       Date:  2004-09       Impact factor: 0.622

10.  Lipopolysaccharide-induced protein kinase D activation mediated by interleukin-1beta and protein kinase C.

Authors:  Ming-Juan Song; Yan-Qing Wang; Gen-Cheng Wu
Journal:  Brain Res       Date:  2007-02-07       Impact factor: 3.252

View more
  20 in total

Review 1.  Protein kinase D signaling: multiple biological functions in health and disease.

Authors:  Enrique Rozengurt
Journal:  Physiology (Bethesda)       Date:  2011-02

2.  Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.

Authors:  Erick Riquelme; Yu Zhang; Liangliang Zhang; Maria Montiel; Michelle Zoltan; Wenli Dong; Pompeyo Quesada; Ismet Sahin; Vidhi Chandra; Anthony San Lucas; Paul Scheet; Hanwen Xu; Samir M Hanash; Lei Feng; Jared K Burks; Kim-Anh Do; Christine B Peterson; Deborah Nejman; Ching-Wei D Tzeng; Michael P Kim; Cynthia L Sears; Nadim Ajami; Joseph Petrosino; Laura D Wood; Anirban Maitra; Ravid Straussman; Matthew Katz; James Robert White; Robert Jenq; Jennifer Wargo; Florencia McAllister
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

3.  Group B Streptococci Induce Proinflammatory Responses via a Protein Kinase D1-Dependent Pathway.

Authors:  Kirtikumar Upadhyay; Jeoung-Eun Park; Tae Won Yoon; Priyanka Halder; Young-In Kim; Victoria Metcalfe; Ajay J Talati; B Keith English; Ae-Kyung Yi
Journal:  J Immunol       Date:  2017-05-01       Impact factor: 5.422

4.  Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells.

Authors:  Fariba Rezaee; Nida Meednu; Jason A Emo; Bahman Saatian; Timothy J Chapman; Nayden G Naydenov; Anna De Benedetto; Lisa A Beck; Andrei I Ivanov; Steve N Georas
Journal:  J Allergy Clin Immunol       Date:  2011-10-11       Impact factor: 10.793

5.  An Evolutionarily Conserved PLC-PKD-TFEB Pathway for Host Defense.

Authors:  Mehran Najibi; Sid Ahmed Labed; Orane Visvikis; Javier Elbio Irazoqui
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

6.  Sustained protein kinase D activation mediates respiratory syncytial virus-induced airway barrier disruption.

Authors:  Fariba Rezaee; Samantha A DeSando; Andrei I Ivanov; Timothy J Chapman; Sara A Knowlden; Lisa A Beck; Steve N Georas
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

7.  PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.

Authors:  Zhipeng Zou; Fangyin Zeng; Wanfu Xu; Chunxia Wang; Zhiyong Ke; Q Jane Wang; Fan Deng
Journal:  J Cell Sci       Date:  2012-07-13       Impact factor: 5.285

8.  Therapeutic potential of microbial modulation in pancreatic cancer.

Authors:  Vidhi Chandra; Florencia McAllister
Journal:  Gut       Date:  2021-04-27       Impact factor: 23.059

9.  A targeted library screen reveals a new inhibitor scaffold for protein kinase D.

Authors:  Manuj Tandon; Lirong Wang; Qi Xu; Xiangqun Xie; Peter Wipf; Qiming Jane Wang
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro.

Authors:  Attila Varga; Pál Gyulavári; Zoltán Greff; Krisztina Futosi; Tamás Németh; Laura Simon-Szabó; Krisztina Kerekes; Csaba Szántai-Kis; Diána Brauswetter; Márton Kokas; Gábor Borbély; Anna Erdei; Attila Mócsai; György Kéri; Tibor Vántus
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.